Zhenghua Su
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 2
-
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 4
- RNA modifications and cancer 2
- Signaling Pathways in Disease 2
- Histone Deacetylase Inhibitors Research 2
-
- PARP inhibition in cancer therapy 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)The FASEB Journal (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
In The Last Decade
Zhenghua Su
16 papers receiving 303 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 52
- Molecular Biology 185
- Rheumatology 40
- Geriatrics and Gerontology 9
- Immunology 39
Countries citing papers authored by Zhenghua Su
This map shows the geographic impact of Zhenghua Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenghua Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenghua Su more than expected).
Fields of papers citing papers by Zhenghua Su
This network shows the impact of papers produced by Zhenghua Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenghua Su. The network helps show where Zhenghua Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhenghua Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 27 | |
| 13 | 2021 | 11 | |
| 14 | 2018 | 54 | |
| 15 | 2018 | 44 | |
| 16 | 2018 | 75 | |
| 17 | 2017 | 18 |
About Zhenghua Su
Zhenghua Su is a scholar working on Physiology, Cancer Research and Molecular Biology, having authored 17 papers that have together received 303 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers), Signaling Pathways in Disease (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related molecular mechanisms research (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (52 citations), Molecular Biology (185 citations) and Rheumatology (40 citations). Zhenghua Su has collaborated with scholars based in China and Macao. Frequent co-authors include Chenxi Xiao, Yi Zhun Zhu, Di Yang, Xinhua Liu, Weijun Wu, Fen Long, Wanwan Jia, Ming Qin, Mengwei Huang and Wen Zhong. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.